Cycloaddition of the diazoalkanes to electron-deficient olefins (in situ) affords polysubstituted cyclopropanes in high yields (up to 85%). Deprotection of the ketal protecting group provided water-soluble cyclopropane-bearing carbohydrate in good yields. Antimicrobial activity screening of the synthesized compounds 8 and 9, utilizing a variety of Gram-positive bacteria (Staphylococcus aureus and Enterococcus fecalis), Gram-negative bacteria (Escherichia coli and Klebsiella pneumoniae) and yeast (Candida albicans), showed that all of the prepared analogues acquire promising activities against both Grampositive and Gram-negative bacteria, especially compounds 9b and 9c (antimicrobial active agents against Gram-negative bacteria).
INTRODUCTION
The cyclopropane ring is a common unit in a diverse range of both naturally occurring and synthetic compounds [1, 2] and many biologically active compounds contain the cyclopropane moiety [3, 4] . The cyclopropane sub-unit is also found in a wide variety of naturally occurring compounds including terpenes, pheromones, fatty acid metabolites, and unnatural amino acids [5, 6] , as well as in rationally designed pharmaceutical agents. Owing to the unique combination of a rigid strained structure and consequent susceptibility to electrophilic attack, the cyclopropane ring often constitutes a key element in complex compounds with a defined orientation of pendant functional groups [7] . Thus, over the past few decades, considerable attention has been devoted to the development of asymmetric methodology for the synthesis of highly functionalized cyclopropanes [8] . Also, carbohydrates constitute a rich source of materials for asymmetric syntheses amplified by a history of well-documented functional group transformations [9, 10] . Carbon-branched sugars [11] are found in numerous natural products. They have been used as starting materials for the preparation of indole alkaloid [12] , commonly occurring in the glycon portion of many antibiotics [13] , and have been studied during the elucidation of biochemical pathways. Additionally, naturally occurring macrolides often contain branched polyol sequences, a structural motif that portends an origin from a C-branched sugar [14] . One of the most important advances in cyclopropane chemistry over the last decade has been the integration of cyclopropanes and carbohydrates [15] . Carbohydrates have an exciting history in organic and medicinal chemistry [16] . Not only are they ubiquitous natural products occurring throughout the biosphere, but also they provide key functional sub-units for rational drug designs [17] . They are inexpensive yet powerful members of the chiral pool, which makes them attractive platforms for asymmetric synthesis [18] . We recently reported a new method for the generation of aryldiazomethanes from stable tosylhydrazone derivatives. This procedure has proven to be a highly effective and safe alternative technique to handle aryldiazomethanes [19] and has been employed in the cyclopropanation of alkenes [20] . The present article reports our success in achieving this goal and the development of a new user-friendly, one-pot procedure for the preparation of cyclopropanes from ketones in which not only the diazoi compound but also the precursor tosylhydrazones are generated in situ.
EXPERIMENTAL SECTION
Melting points (Mp) were determined in open capillaries on a Buchi-510 Melting Point apparatus and are uncorrected. IR spectra were obtained on a Perkin-Elmer IR-197 spectrometer. NMR spectra were obtained on a Bruker AC 300 spectrometer operating at 300 MHz for 1 H and at 75.47 MHz for 13 C. Mass spectra were acquired in ESI mode. Optical rotations were measured at 589 nm. TLC was performed on pre-coated plates (0.2 mm, silica gel 60 F254). All solvents were distilled and purified prior to use. (2,2,7,7-tetramethyltetrahydro-bis [1, 3] dioxolo [4,5- 
General procedure for the synthesis of 4-methyl-1-phenyl-2-
Pyridazine-3,6-dione 2 (1.0 mmol, 222 mg) was added to a stirred solution (spin bar) of 1ꞌ,2ꞌ:3ꞌ,4ꞌ-di-O-isopropylidene-α-D-galactopyranose 1 (1.1 mmol, 286 mg) and triphenyl-phosphine (1.1 mmol, 262 mg) in anhydrous THF under a nitrogen atmosphere at 0 °C. To the resulting suspension (or solution) was added diethyl azodicarboxylate (1.1 mmol, 174 mg) and the reaction mixture was then stirred at room temperature until completion of the reaction, as indicated by TLC on silica gel TLC (hexane-EtOAc, 80:20). The precipitated diethyl hydrazodicarboxylate was collected and the filtrate was evaporated in vacuo. Addition of cyclohexane to the oily residue caused the precipitation of triphenylphosphine oxide which was collected. Evaporation of the filtrate under reduced pressure gave a residue that was purified by column chromatography on silica gel to afford the pure compounds. A mixture of the ketone (1.5 mmol) and ptoluenesulfonylhydrazide (279 mg, 1.5 mmol) in 10 ml. of 95% ethanol was stirred for 3 h at room temperature. Then, a 5N NaOH (300 μl, 1.5 mmol) solution was added and the mixture was stirred for a further 20 min. The pyridazinedione 3 (7.5 mmol) was then added as a solid, and the mixture was heated up to 50 °C and stirred at this temperature for 48 h. After cooling, the volatiles were evaporated under reduced pressure and the residue was dissolved in a 1:1 mixture of water-ethyl acetate (70 ml). The organic layer was separated and dried over MgSO 4 . Filtration and evaporation of the filtrate under reduced pressure led to the crude material which was purified by flash column chromatography (hexane-EtOAc, 85:15). 
Deprotection of cyclopropanes 7
To a solution of cyclopropanes 7 (1 mmol) in 8 ml of anhydrous methanol, was added a catalytic (20 mg) amount of sodium was added. The reaction was stirred for 2 h then neutralized by the addition of 200 mg of acidic Amberlite ® IR-120 resin. The reaction mixture was filtered to remove the resin and the solvent was re-evaporated under reduced pressure to give a diastereo-isomeric mixture of 8 and 9. (1R,6S,1ꞌS,2ꞌS,3ꞌS,4ꞌR)-1-methyl-4 (1R,6S,1ꞌS,2ꞌR,3ꞌS,4ꞌR)-1-methyl-4,7,7-triphenyl-3-(3,4,5,6-tetrahydroxytetrahydropyran-2 (1R,6S,1ꞌS,2ꞌS,3ꞌS,4ꞌR)-1-methyl-7-(4-nitro-phenyl)-7-(3-nitro-phenyl)-4-phenyl-3-(3,4,5, 6)-(3,4,5,  6-tetrahydroxy-tetrahydro-pyran-2-ylmethyl) (1R,6S,1ꞌS,2ꞌR,3ꞌS,4ꞌR) (1R,6S,1ꞌS,2ꞌS,3ꞌS,4ꞌR)-7,7-bis-(4-methoxyphenyl)-1-methyl-4-phenyl-3-(3,4,5,6-tetrahydroxy-tetrahydro-pyran-2-ylmethyl)-3,4-diaza-bicyclo[ (1R,6S,1ꞌS,2ꞌR,3ꞌS,4ꞌR)7,7-bis-(4-methoxyphenyl)-1-methyl-4-phenyl-3-(3,4,5,6-tetrahydrox-tetrahydro-pyran-2-ylmethyl)-3,4-diaza-bicyclo[ 
Antimicrobial activity screening
Antimicrobial activity screening of the synthesized compounds 8 and 9 was performed by the agar dilution technique as recommended by the Clinical and Laboratory Standard Institute (CLSI) [21] . The tested compounds were dissolved in dimethyl sulfoxide (DMSO). An inoculum of about 1.5-108 colony forming unit (CFU) per spot was applied to the surfaces of Mueller-Hinton agar plates containing graded concentrations of the respective compound; plates were incubated at 37 °C for 18 h. The spot with the lowest concentration of compound showing no growth was defined as the minimum inhibitory concentration (MIC). All organisms used in this study were standard strains obtained from American Type Culture Collection (ATCC). The organisms included representatives of Gram-positive bacteria (S. aureus 25923 and E. fecalis 29212), Gram-negative bacteria (E. coli 25922 and K. pneumoniae 33495) and yeast (C. albicans 20260). The MIC of Ciprofloxacin and Amphotericin B was determined concurrently as reference for antibacterial activities, respectively (Table 2) . Control DMSO was used with each experiment.
RESULTS AND DISCUSSION
The 4-methyl-1-phenyl-1,2-dihydropyridazine-3,6-dione derivative of D-(+)-galactose 3 was prepared according to literature procedures. Primary alcohol 1 was converted into 4-methyl-1-phenyl-1,2-dihydro-pyridazine-3,6-dione N-glycoside 3 in excellent yield (90%) by a Mitsunobu reaction with 4-methyl-1-phenyl-1,2-dihydro-pyridazine-3,6-dione 2 in the presence of triphenylphosphine and diethyl azodicarboxylate (Scheme 1). Since preliminary experiments showed that diazoalkanes could also be generated in situ from ketones 4 in a one-pot process, condensation of ptosylhydrazine with ketones followed by treatment with an aqueous solution of sodium hydroxide led to a solution of ketone tosylhydrazones sodium salt 5, which upon warming to 50 °C gave a solution of aryldiazomethanes 6, as heralded by formation of the characteristic deep red color [21] . For the purpose of the present investigation, 4-methyl-1-phenyl-1,2-dihydro-pyridazine-3,6-dione derivative of D-(+)-galactose 3 was added prior to warming the reaction mixture to provide the desired cyclopropanes 7 in good yields (Scheme 2). The intermediate of this reaction is pyrazoline which was not separated. It was found that thermal 1,3-dipolar cycloaddition followed by nitrogen extrusion gave cyclopropane [22] . The 1,3-dipolar cycloaddition of aryldiazomethanes 6 with 4-methyl-1-phenyl-1,2-dihydropyridazine-3,6-dione derivative of D-(+)-galactose 3 was completely stereoselective; a syn configuration was assigned to all cyclopropanes. The structure and stereochemistry were unambiguously established by NMR 2D. Crucial evidence for the stereochemistry was obtained by nuclear Overhauser effect spectroscopy (NOESY). The spectrum shows that protons between (CH 3 ) 1 and H 6 have strong nuclear Overhauser effect. This results confirms the cis relationships between protons (CH 3 ) 1 and H 6. Accordingly, the stereochemistry of 7a was concluded (Fig. 1) . The choice of the protective group was important to the outcome of the cycloaddition and for the deprotection of the adducts. Deprotection of 7 by basic hydrolysis followed by acidic treatment [23] provided the known water soluble carbohydrates 8 and 9 in good yields (Table 1) .
Antimicrobial activity screening of the synthesized compounds 8 and 9 was determined by the agar dilution technique, as recommended by the Clinical and Laboratory Standard Institute (CLSI) [24] , utilizing a variety of Gram-positive bacteria (Staphylococcus aureus and Enterococcus fecalis), Gram-negative bacteria (Escherichia coli and Klebsiella pneumoniae) and yeast (Candida albicans). From the obtained results (Table 1 ) it has been noticed that all of the tested compounds exhibit promising antimicrobial properties against both Gram-positive and Gram-negative bacteria.
However, all of the tested compounds seem completely inactive against the used yeast strain (C. albicans). It has also generally been noticed that compounds 9 are more effective antibacterial agents than compounds 8. Also, compounds 9b and 9c seem to be the most effectively prepared Gram-negative antibacterial agents. This may be attributed to the role of anisyl function attachment to cyclopropane ring system as the most observed enhancing antibacterial properties moiety comparable with the other adopted residues.
T a b l e 1
Synthesis of cyclopropane derivatives 8 and 9
MeONa, MeOH, r.t. In conclusion, we have developed a simple preparation of glycol-cyclopropanes from a carbohydrate-derived precursors via a 1,3-dipolar cycloaddition reaction of aromatic diazo compounds generated in situ in a one-pot sequence from the ketones and tosylhydrazine. To the best of our knowledge, this is the first report of the synthesis of sugar-fused cyclopropanes heterocycles with an attached pyridazine-3,6-dione core by means of 1,3-dipolar cyclo-addition of aromatic diazoalkanes. Cleavage of the ketal protecting groups provided water-soluble cyclopropane-bearing carbohydrates 8 and 9. These compounds were tested for antimicrobial properties against both Grampositive and Gram-negative bacteria. From these studies, compounds 9b and 9c emerged as the lead compounds, which showed maximum antimicrobial activity. Thus, compound 9c represents a fruitful matrix for the development of a new class of antimicrobial agent that deserves further investigation and derivatization.
